Insulin Glulisine (Apidra)

Ultra-rapid acting insulin analogue with glycine/lysine modifications at B-chain. HTS 2937.12.00.00 covers rDNA-produced structural analogues used primarily as polypeptide hormones.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
🇨🇳ChinaFreeFree
🇲🇽MexicoFreeFree
🇨🇦CanadaFreeFree
🇩🇪GermanyFreeFree
🇯🇵JapanFreeFree

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

3004.39.00Same rate: Free

If in prefilled injection devices

Pharmaceutical dosage forms containing insulin classify under Chapter 30.

2937.12.00Same rate: Free

If no viable alternative within heading

All insulin analogues specifically enumerated in this subheading.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

Sequence analysis certificate confirming glulisine modifications essential

Maintain refrigerated conditions; ultra-rapid analogues have narrow stability window

API vs finished product distinction critical for correct HTS classification

Related Products under HTS 2937.12.00.00

Human Insulin (rDNA)

Recombinant human insulin produced via DNA technology, a polypeptide hormone used primarily for treating diabetes mellitus. Classified under HTS 2937.12.00.00 as a synthetic reproduction of insulin, the exact structural analogue of natural human insulin. Meets chapter 29 requirements for chemically defined organic compounds used as hormones.

Insulin Lispro (Humalog)

Rapid-acting insulin analogue created by recombinant DNA technology with amino acid modifications for faster absorption. Falls under HTS 2937.12.00.00 as a structural analogue of insulin used primarily as a hormone for glycemic control. Qualifies as a chain-modified polypeptide hormone per chapter notes.

Insulin Glargine (Lantus)

Long-acting basal insulin analogue produced by recombinant DNA, modified for prolonged release profile. HTS 2937.12.00.00 covers this as a derivative and structural analogue of insulin used primarily as a hormone. Chemically defined polypeptide meeting Chapter 29 hormone classification criteria.

Insulin Aspart (NovoRapid)

Fast-acting insulin analogue with aspartic acid substitution, rDNA origin, used for mealtime glycemic control. Classified in 2937.12.00.00 as insulin structural analogue per heading description for chain-modified polypeptides used as hormones.

Insulin Detemir (Levemir)

Soluble long-acting insulin analogue with fatty acid modification for albumin binding. HTS 2937.12.00.00 applies to this rDNA-produced derivative used primarily as a basal insulin hormone replacement.

Insulin Sodium Salt USP

Pharmaceutical grade sodium salt of bovine or porcine insulin meeting USP standards. Explicitly covered by HTS 2937.12.00.00 as 'insulin and its salts' for therapeutic hormone use.